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ABSTRACT
Purpose: The purpose of MOthers and BAbies in
Norway and Denmark cerebral palsy (MOBAND-CP)
was to study CP aetiology in a prospective design.
Participants: MOBAND-CP is a cohort of more than
210 000 children, created as a collaboration between
the world’s two largest pregnancy cohorts—the
Norwegian Mother and Child Cohort study (MoBa) and
the Danish National Birth Cohort. MOBAND-CP
includes maternal interview/questionnaire data collected
during pregnancy and follow-up, plus linked
information from national health registries.
Findings to date: Initial harmonisation of data from
the 2 cohorts has created 140 variables for children
and their mothers. In the MOBAND-CP cohort, 438
children with CP have been identified through record
linkage with validated national registries, providing by
far the largest such sample with prospectively collected
detailed pregnancy data. Several studies investigating
various hypotheses regarding CP aetiology are
currently on-going.
Future plans: Additional data can be harmonised as
necessary to meet requirements of new projects.
Biological specimens collected during pregnancy and
at delivery are potentially available for assay, as are
results from assays conducted on these specimens for
other projects. The study size allows consideration of
CP subtypes, which is rare in aetiological studies of
CP. In addition, MOBAND-CP provides a platform
within the context of a merged birth cohort of
exceptional size that could, after appropriate
permissions have been sought, be used for cohort and
case-cohort studies of other relatively rare health
conditions of infants and children.
INTRODUCTION
During the 1990s, researchers from
Denmark and Norway collaborated in the
planning of two large pregnancy cohort
studies: the Danish National Birth cohort
(DNBC)1 and the Norwegian Mother and
Child Cohort Study (MoBa).2 3 Each cohort
aimed to enrol 100 000 pregnancies using
similar methods. The Danish cohort com-
pleted its enrolment in 2002 and the
Norwegian cohort completed its enrolment
in 2009. Both national birth cohorts include
information on a range of exposures during
pregnancy collected via maternal interviews/
questionnaires and biological samples, for
example, information on maternal nutrition,
medications and medical conditions during
pregnancy and delivery. Except for within a
few larger European cross-cohort collabora-
tions,4 5 and for nutrition data,6 few efforts
have been made to use the data combined.
In 2010, the US National Institute of
Environmental Health Sciences (NIEHS)
partnered with the DNBC and the
Norwegian Institute of Public Health to form
a collaborative project called MOBAND (for
MOthers and BAbies in Norway and
Denmark). The cerebral palsy (CP) study,
described here as MOBAND-CP, includes a
Steering Committee, a Scientiﬁc Advisory
Board of CP experts and a network of collab-
orating investigators addressing speciﬁc
aspects of CP. The purpose was to create
from the two Scandinavian cohorts a single
platform that could extend the possibilities
Strengths and limitations of this study
▪ The MOthers and BAbies in Norway and
Denmark cerebral palsy cohort has data collected
prospectively and repeatedly during pregnancy
for more than 200 000 children, minimising
recall bias.
▪ Children with cerebral palsy were identified
through record linkage with validated national
health registries.
▪ Participating mothers were older and more
socioeconomically privileged than the general
population, and data were collected mainly by
telephone interview in Denmark and question-
naires in Norway, which may influence the
results.
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for studying prenatal risk factors associated with rare
diseases in infants and children, speciﬁcally CP.
CP originates from non-progressive damage to the
immature brain and is the most common cause of phys-
ical disability in children, affecting ∼2 in 1000 live
births.7 It comprises several more-or-less distinct subtypes
with a wide spectrum of severity of motor disability and
is often accompanied by visual impairment, intellectual
deﬁcit or epilepsy.8 9 Preterm delivery is one of the
strongest risk factors identiﬁed, but also atypical intra-
uterine growth, congenital malformations, placental
pathology, intrauterine infection, multiple fetuses and
perinatal stroke are recognised as risk factors in preg-
nancy and the perinatal period.10–12 CP runs in fam-
ilies,13 but current understanding of underlying genetics
is limited. However, ongoing investigations making the
use of techniques like high-throughput whole-genome
sequencing may soon improve our understanding of the
underlying heterogeneous and complex risk genetic
factors for CP.14 15
Most previous studies of CP aetiology have had low
statistical power or have been hampered by retrospective
collection of pregnancy exposure data. The two com-
bined pregnancy cohorts provide an excellent opportun-
ity for the study of CP. While the origins of CP are
thought to lie in fetal life, the condition is too rare to be
studied in moderate-sized pregnancy cohorts.
Meanwhile, conventional case–control studies of CP are
limited by the fact that CP diagnosis is typically not ﬁnal
before the age of 4 years, at which time it can be
difﬁcult to reconstruct the conditions and exposures of
pregnancy. The combination of the Norwegian and
Danish pregnancy cohorts addresses both of these study
limitations by allowing case-cohort analyses within a
cohort of unusual size.
COHORT DESCRIPTION
Participants and data collection in Denmark
In Denmark, 91 385 women were recruited to the DNBC
at their ﬁrst antenatal visit (around week 6–10 of preg-
nancy). Some women contributed more than one preg-
nancy, for a total of 100 417 pregnancies and 96 836
live-born children delivered during 1996–2003.16
Pregnant women in the DNBC ﬁlled in a brief recruit-
ment questionnaire at the time of enrolment, partici-
pated in a telephone interview approximately week 16,
completed a food frequency questionnaire in week 25
and were interviewed again around week 31 and at
about 6 and 18 months postpartum (table 1).
Maternal blood samples were collected in the ﬁrst
trimester and at midpregnancy, and cord blood was
collected at delivery. Additional waves of postdelivery
data collection have not yet been incorporated into the
harmonised data.
Participants and data collection in Norway
In Norway, 95 093 women were recruited to MoBa at the
time they received their invitation to a routine ultra-
sound examination (around week 13–17 of pregnancy).
Table 1 Cohorts and data used in the MOBAND-CP collaboration
Denmark Norway
Birth cohort DNBC MoBa
Recruitment
Years 1995–2002 1999–2008
Time in pregnancy Week 6–10 Week 13–17
Participating women (n) 91 385 95 093
Recruited pregnancies (n) 100 417 112 509
Pregnancies resulting in live birth (n) 94 747 111 618
Live births (singletons and multiples) 96 836 113 564
Stillbirths 329 281
Data used (from pregnancies resulting in live birth)
1st questionnaire (approximately week 17) 101 181
1st interview (approximately week 16) 88 750
3rd questionnaire (approximately week 30) 93 844
2nd interview (approximately week 31) 86 155
Questionnaire 6 months postpartum 88 106
Interview 6 months postpartum 70 281
Interview 18 months postpartum 66 705
Verified CP cases (per 1000 live births) 191 (2.0) 247 (2.2)
Spastic unilateral (per 100 CP cases) 71 (37) 98 (40)
Spastic bilateral (per 100 CP cases) 97 (51) 107 (43)
Dyskinetic (per 100 CP cases) 17 (9) 21 (9)
Ataxic (per 100 CP cases) 3 (2) 14 (6)
Not classified (per 100 CP cases) 3 (2) 7 (3)
CP, cerebral palsy; DNBC, Danish National Birth Cohort; MoBa, Norwegian Mother and Child Cohort Study.
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As in Denmark, MoBa many women contributed more
than one pregnancy. In the data ﬁles used for the
MOBAND-CP harmonisation, there were a total of
112 509 pregnancies and 113 564 live births during
1999–2009. Pregnant women in MoBa were invited to ﬁll
in a pregnancy questionnaire around week 13–17, a
food frequency questionnaire around week 22 and a
second pregnancy questionnaire around week 30.
Additional questionnaires were distributed when chil-
dren were 6 and 18 months old. Maternal blood and
urine samples were collected at enrolment, plus cord
blood and (eventually) deciduous teeth from the chil-
dren. As with the Denmark cohort, further waves of
Norwegian data collection are not yet included in the
harmonised data.
Attrition
Approximately 60% of the Danish women invited to par-
ticipate in DNBC agreed to participate.17 Of the 94 747
enrolled pregnancies that resulted in a live birth, 94% of
the mothers participated in the ﬁrst pregnancy
interview, 91% in the second pregnancy interview, 74%
in the 6-month-postpartum interview and 70% in the
18-month-postpartum interview.
In Norway, 41% of invited women agreed to partici-
pate in MoBa.18 Of the 111 618 pregnancies that
resulted in a live birth, 91% of the mothers completed
the ﬁrst pregnancy questionnaire, 84% the third
pregnancy questionnaire and 79% completed the
6-month-postpartum questionnaire (table 1).
Data harmonisation
The ﬁrst task of the MOBAND-CP collaboration was to
harmonise epidemiological variables from the two
cohorts. A list of prioritised variables for CP research
was created and reﬁned through circulation among the
collaborators. Initial harmonisation efforts have focused
on variables considered essential for epidemiological
research, in general, and for CP research, in particular.
These include maternal and paternal characteristics,
exposures during pregnancy, maternal medical condi-
tions during pregnancy, delivery, birth characteristics
and newborn conditions (see online supplementary
table).
Data collections in the two cohorts were similar but by
no means identical. A plan for harmonising each vari-
able was developed through discussions and revisions
involving Danish and Norwegian collaborators. The
success of each harmonisation was judged as ‘complete’,
‘partial’ or ‘impossible’. Once agreement on harmonisa-
tion was reached, code was written in Stata (V.12.1; Stata
Corporation, College Station, Texas, USA). Code and
documentation for each variable, including minutes
from all meetings, have been posted on a secure
DokuWiki website, accessible by username and
password.
By 2016, data had been harmonised for 140 variables.
Guidelines have been created for further harmonisation
of data, with the expectation that future investigators
may contribute additional harmonised variables. Data
(including the raw data underlying the harmonised vari-
ables) will be accessible through a secure server at the
National Institute of Public Health, Norway and the
central data server for the DNBC.
Linkage to national registries and identification of children
with CP
Unique national identiﬁcation numbers in both coun-
tries allowed cohort participants to be linked to add-
itional data in the medical birth registries of the two
countries,19 20 as well as in the Danish National Patient
Register,21 the Norwegian Patient Register22 and the
Danish IVF Register.23
Children with CP in Denmark (191 in total) have
been identiﬁed through record linkage with the
Cerebral Palsy Registry of Denmark.24 In Norway, 247
children with CP have been identiﬁed, nearly 90%
through record linkage with the Cerebral Palsy Registry
of Norway.25 The remainder have come through record
linkage with the Norwegian Patient Registry,22 validated
through medical record review by two paediatric
neurologists.26
FINDINGS TO DATE
Data had been harmonised for 140 variables, and 438
children with CP identiﬁed through record linkage with
national registries. Collaborating investigators have devel-
oped protocols for the analysis of exposures plausibly
linked to the risk of CP. Results from these analyses will
inform future studies that make use of biological speci-
mens collected during pregnancy. The ﬁrst papers from
the MOBAND-CP project (now in preparation) explore
speciﬁc hypotheses on maternal alcohol and caffeine
consumption, pre-pregnancy body mass index, thyroid
disorders and use of over-the-counter pain medication
in relation to risk of CP.
STRENGTHS AND LIMITATIONS
Strengths of the study include prospectively collected
exposure data, an exceptionally large sample size and
the opportunity to follow all participants through lin-
kages to national health registries. Denmark and Norway
are similar in many respects, sharing culture, history,
political systems and high standards of living and educa-
tion levels. These cultural similarities support the practi-
cality of harmonising variables across the two studies.
At the same time, there are important differences
between the two studies and between the two countries.
Data were collected primarily by telephone interview in
Denmark and by questionnaire in Norway. How this may
affect the harmonised data is difﬁcult to evaluate. Also,
varying differences between the two cohorts in the
format of questions (or between the substance of
the questions themselves) leads to loss of information in
the harmonisation process. Nonetheless, harmonisation
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for 42 of the 143 variables in our initial round were
scored as ‘complete’ and 98 were scored as ‘partial’ with
only three regarded as ‘impossible’. Variables were con-
sidered impossible to harmonise if information was
missing from one of the cohorts or format or content was
considered too different to generate a meaningful
common ground. All these judgments are of course sub-
jective, and open to other interpretation by future
investigators.
As usual in pregnancy cohort studies, participants are
older and more socioeconomically privileged than the
general population.2 17 Self-selection affects the preva-
lence of exposures and outcomes, but estimates of
known exposure-outcome associations in the DNBC and
MoBa generally appear to be unbiased.27 28 Norway and
Denmark have fairly large immigrant populations, but
few immigrants participated in either cohort study. The
study is also limited by the data collected; for instance,
information on placentas is limited to weight, and
imaging data to what is recorded in the CP registries.
With regard to the current study of CP, the 438 cases
provide by far the largest sample of children with CP with
prospectively collected detailed pregnancy data. This
study of more than 200 000 mother–child pairs permits
the detection of a relative risk of 1.5 for CP for an expos-
ure with a prevalence of 10%, assuming conventional
levels for statistical signiﬁcance (80% power and 5% α
level).29 The validation of the CP cases in the national
registries using medical records is a deﬁnite strength.
Furthermore, the large study size allows consideration of
CP subtypes, which is rare in aetiological studies of CP.
COLLABORATION
The purpose and permissions of MOBAND-CP are to
foster studies on CP. Investigators with an interest in
hypotheses related to CP (and that meet the requirements
of current approvals) are welcome to contact a member of
the Steering Committee (Allen Wilcox, Camilla
Stoltenberg or Anne-Marie Nybo Andersen). We antici-
pate future opportunities for the study of other infant and
childhood outcomes based on the harmonisation efforts
made for MOBAND-CP. Such studies would require
regular application for data access from both cohorts (see
more information on the individual cohorts’ websites30 31),
after which an application to the MOBAND steering com-
mittee to access the MOBAND DokuWiki website, with
codes for data harmonisation and documentation, would
be considered. The application should include a brief
description of the project, which must include involve-
ment of collaborators from Norway and Denmark.
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